Details

Načelo učinkovitosti razvojne pomoči Evropske unije in Kitajske Mozambiku : doktorska disertacija
ID Pliberšek, Eva (Author), ID Bučar, Maja (Mentor) More about this mentor... This link opens in a new window

URLURL - Presentation file, Visit http://dk.fdv.uni-lj.si/doktorska_dela/pdfs/dr_nastav-eva.pdf This link opens in a new window

Language:Slovenian
Keywords:mednarodno razvojno sodelovanje, učinkovitost pomoči
Work type:Dissertation
Typology:2.08 - Doctoral Dissertation
Organization:FDV - Faculty of Social Sciences
Place of publishing:Ljubljana
Publisher:[E. Nastav]
Year:2014
Number of pages:306 str.
PID:20.500.12556/RUL-29413 This link opens in a new window
UDC:339.96(6)(043.3)
COBISS.SI-ID:32824669 This link opens in a new window
Publication date in RUL:01.09.2014
Views:1963
Downloads:334
Metadata:XML DC-XML DC-RDF
:
PLIBERŠEK, Eva, 2014, Načelo učinkovitosti razvojne pomoči Evropske unije in Kitajske Mozambiku : doktorska disertacija [online]. Doctoral dissertation. Ljubljana : E. Nastav. [Accessed 30 March 2025]. Retrieved from: http://dk.fdv.uni-lj.si/doktorska_dela/pdfs/dr_nastav-eva.pdf
Copy citation
Share:Bookmark and Share

Similar documents

Similar works from RUL:
  1. Systematic review and meta-analysis of observational studies evaluating treatment outcomes in patients with metastatic non-small-cell lung cancer on first-line immune checkpoint inhibitors therapy
  2. Description of adverse event of immune checkpoint inhibitors in patients with advanced non-small cell lung cancer treated at the University Clinic Golnik
  3. Effectivness and safety of immunotherapy in patients with advanced non-small cell lung cancer in second line treatment at the University Clinic Golnik
  4. Evaluation of possible pembrolizumab dosing regimen racionalisation in advanced non-small cell lung cancer
  5. ǂThe ǂpotential of immunotherapies in the treatment of lung cancer
Similar works from other Slovenian collections:
  1. ǂThe ǂrole of immune checkpoint inhibitors in the treatment of cancer of unknown origin
  2. Trans-esophageal endobronchial ultrasound-guided needle aspiration (EUS-B-NA)
  3. Febrile neutropenia and grade 3/4 neutropenia in daily practice of adjuvant chemotherapy for non-small-cell lung cancer
  4. Advances in the therapy with immune-check point inhibitors (ICI) in non-small cell lung cancer (NSCLC) in 2022
  5. Long-term survival of locally advanced stage III non-small cell lung cancer patients treated with chemoradiotherapy and perspectives for the treatment with immunotherapy

Back